Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Feature

Abbott issues patch for vulnerable heart devices

August 31, 2017 Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …
News
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
Appointment
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017 Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
News
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.
News

Novartis names new Chief Digital Officer

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
Appointment
adults-1853851_960_720

Thyroid disorders: An illness underestimated

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
Feature
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

August 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
News
goggles-1683644_960_720

The pharmacovigilance market dynamic

August 25, 2017 Medical Communications biotech, drugs, pharma, pharmaceutical, pharmacoviglance

Pharmacovigilance is a science of understanding drug safety through identification, assessment, and prevention of adverse drug reactions (ADRs). It is …
News
merck_kgaa_pyramid_use_with_credit

Seven years later, EC gives approval for Merck KGaA’s MS drug

August 25, 2017 Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
News
samsung_bioepis_engineer_4

Samsung completes hat-trick of big biosimilar approvals

August 25, 2017 Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical

Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
News
manufacturing_image_1

‘Trade secret information’ to be shared between EMA and FDA

August 25, 2017 Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical

As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …
News

Novartis names new Chief Digital Officer

August 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment, digital pharma, life sciences, pharma, pharmaceuticals

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
News
640px-sq_lethal_injection_room

Janssen opposes use of its drug in state execution

August 23, 2017 Medical Communications, Research and Development, Sales and Marketing Janssen, etomidate, life sciences, pharma, pharmaceutical

Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, …
News

Outcry after private hospitals receive tax breaks instead of NHS

August 22, 2017 Manufacturing and Production, Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025